ECO ANIMAL HEALTH GROUP PLC

Share Issue/Capital Change • Oct 31, 2022

National Storage Mechanism | Additional information

RNS Number : 5464E

Eco Animal Health Group PLC

31 October 2022

31 October 2022

ECO Animal Health Group PLC

BLOCK LISTING RETURN

Date: 31 October 2022

Name of applicant:		ECO Animal Health Group plc
Name of scheme:		Executive Share Option Scheme and Unapproved Share Option Scheme
Number and class of securities originally listed and the date of admission:		1,500,000 ordinary shares of 5 pence each on 20 July 2017
Period of return:	From:	29 April 2022	To:	31 October 2022
Balance of unallotted securities under scheme(s) from previous return:		375,505
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period:		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		375,505

For further information, please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
IFC Advisory Graham Herring Zach Cohen	020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas	020 7496 3000
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi Peel Hunt LLP (Joint Broker) Dr Christopher Golden James Steel	020 7597 5970 020 7418 8900

Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRPPGRCUUPPGCR